Access cutting-edge malignant peripheral nerve sheath tumors treatment through this clinical trial at a research site in Providence. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Providence location
Preparing your pre-screening questions…
Access malignant peripheral nerve sheath tumors specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related malignant peripheral nerve sheath tumors treatment provided free
Check if you qualify for this malignant peripheral nerve sheath tumors clinical trial in Providence, RI
No-Cost Study Care
Local to Providence
Convenient for RI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A worldwide database will be established, collecting, in a standardized manner, histologic, immunohistochemical, molecular, radiographic, treatment, and related clinical data from centers worldwide with expertise in these NF1-related cancers. Although retrospective in nature, the resulting data from this registry may reveal previously unanticipated patterns, similar to the INFACT effort outcome. This registry would then allow the acquisition of data associated with MPNST biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing data for aggregate analyses). Second, the investigators plan to co-register patients to institutional banks in order to prospectively collect MPNST samples for analysis. These patients will be consented in order to collect the above information and for banking of tumor tissue and future studies that include genomic characterization of the tumors.
Sponsor: Washington University School of Medicine
Yes, this clinical trial (NCT03141021) has an active research site in Providence, RI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for malignant peripheral nerve sheath tumors treatment options in Providence, RI, this clinical trial (NCT03141021) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Providence research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant peripheral nerve sheath tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all malignant peripheral nerve sheath tumors clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Providence — not just this study.
Browse Pulmonary Embolism Trials in Providence →